Ethiopia: Bold Move to Foster Pharmaceutical Industry

Posted on :Saturday , 29th August 2015

Pharmaceutical excipients are no longer inert materials but are effective and able to improve the characteristics of the products' quality, stability, functionality, safety, solubility and acceptance of patients. It can interact with the active ingredients and alter the medicament characteristics. The globalization of medicines' supply enhances the importance of globalized good manufacturing practice (GMP) requirements for pharmaceutical excipients.

Understanding the expansion of pharmaceutical manufacturing to ensure access to medicine, Ethiopia launched an ambitious 10-year national strategy and plan of action to develop local pharmaceutical manufacturing capacity in order to increase access to locally manufactured and quality-assured medicines.

The World Health Organization (WHO), in collaboration with the European Union Commission and Bill and Melinda Gates Foundation, provided technical assistance to the Government of Ethiopia in the development of this strategy, the first of its kind in the country.

As part of the flagship programme of the Growth and Transformation Plan, Ethiopia has launched a decade-long awaited National Strategy and Plan of Action for Pharmaceuticals Manufacturing Development.

Presenting an overview of the National Strategy and Plan of Action for Pharmaceutical Manufacturing Development in Ethiopia (2015-2025) at the programme, Prof. Tsige Gebre-Mariam of Addis Ababa University School of Pharmacy, pointed out the seven key objectives of this ambitious plan.

Expogroup

Expogroup is a full service exhibition organiser with over 28 years experience in International trade exhibitions. Our current portfolio includes 28 annual exhibitions from a diverse range of industries being held across the Middle East & Africa.

Facebook

EXPOGROUP